127 related articles for article (PubMed ID: 19735079)
1. Proteasome inhibition activates the mitochondrial pathway of apoptosis in human CD4+ T cells.
Berges C; Haberstock H; Fuchs D; Sadeghi M; Opelz G; Daniel V; Naujokat C
J Cell Biochem; 2009 Nov; 108(4):935-46. PubMed ID: 19735079
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells.
Qin JZ; Ziffra J; Stennett L; Bodner B; Bonish BK; Chaturvedi V; Bennett F; Pollock PM; Trent JM; Hendrix MJ; Rizzo P; Miele L; Nickoloff BJ
Cancer Res; 2005 Jul; 65(14):6282-93. PubMed ID: 16024630
[TBL] [Abstract][Full Text] [Related]
3. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
[TBL] [Abstract][Full Text] [Related]
4. JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways.
Lauricella M; Emanuele S; D'Anneo A; Calvaruso G; Vassallo B; Carlisi D; Portanova P; Vento R; Tesoriere G
Apoptosis; 2006 Apr; 11(4):607-25. PubMed ID: 16528474
[TBL] [Abstract][Full Text] [Related]
5. The proteasome inhibitor bortezomib sensitizes melanoma cells toward adoptive CTL attack.
Seeger JM; Schmidt P; Brinkmann K; Hombach AA; Coutelle O; Zigrino P; Wagner-Stippich D; Mauch C; Abken H; Krönke M; Kashkar H
Cancer Res; 2010 Mar; 70(5):1825-34. PubMed ID: 20179203
[TBL] [Abstract][Full Text] [Related]
6. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
Pahler JC; Ruiz S; Niemer I; Calvert LR; Andreeff M; Keating M; Faderl S; McConkey DJ
Clin Cancer Res; 2003 Oct; 9(12):4570-7. PubMed ID: 14555532
[TBL] [Abstract][Full Text] [Related]
7. SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib.
Emanuele S; Lauricella M; Carlisi D; Vassallo B; D'Anneo A; Di Fazio P; Vento R; Tesoriere G
Apoptosis; 2007 Jul; 12(7):1327-38. PubMed ID: 17351739
[TBL] [Abstract][Full Text] [Related]
8. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
Wu SJ; Ng LT; Lin CC
Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
[TBL] [Abstract][Full Text] [Related]
9. Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases.
Srimatkandada P; Loomis R; Carbone R; Srimatkandada S; Lacy J
Eur J Haematol; 2008 May; 80(5):407-18. PubMed ID: 18221384
[TBL] [Abstract][Full Text] [Related]
10. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P
Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938
[TBL] [Abstract][Full Text] [Related]
11. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
Pei XY; Dai Y; Grant S
Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
[TBL] [Abstract][Full Text] [Related]
12. Early activation of the mitochondrial apoptotic pathway in Vesicular Stomatitis virus-infected cells.
Gadaleta P; Perfetti X; Mersich S; Coulombié F
Virus Res; 2005 Apr; 109(1):65-9. PubMed ID: 15826914
[TBL] [Abstract][Full Text] [Related]
13. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells.
Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
J Cell Biochem; 2008 Jan; 103(1):270-83. PubMed ID: 17516511
[TBL] [Abstract][Full Text] [Related]
14. Helenalin suppresses essential immune functions of activated CD4+ T cells by multiple mechanisms.
Berges C; Fuchs D; Opelz G; Daniel V; Naujokat C
Mol Immunol; 2009 Sep; 46(15):2892-901. PubMed ID: 19656571
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species induced by proteasome inhibition in neuronal cells mediate mitochondrial dysfunction and a caspase-independent cell death.
Papa L; Gomes E; Rockwell P
Apoptosis; 2007 Aug; 12(8):1389-405. PubMed ID: 17415663
[TBL] [Abstract][Full Text] [Related]
16. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036.
Shiah HS; Lee WS; Juang SH; Hong PC; Lung CC; Chang CJ; Chou KM; Chang JY
Biochem Pharmacol; 2007 Mar; 73(5):610-9. PubMed ID: 17150195
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
19. Regulation of apoptosis proteins in cancer cells by ubiquitin.
Zhang HG; Wang J; Yang X; Hsu HC; Mountz JD
Oncogene; 2004 Mar; 23(11):2009-15. PubMed ID: 15021888
[TBL] [Abstract][Full Text] [Related]
20. Bisphenol A diglycidyl ether-induced apoptosis involves Bax/Bid-dependent mitochondrial release of apoptosis-inducing factor (AIF), cytochrome c and Smac/DIABLO.
Fehlberg S; Gregel CM; Göke A; Göke R
Br J Pharmacol; 2003 Jun; 139(3):495-500. PubMed ID: 12788809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
